Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data 24/03/2023 (VOVWORLD) - Sanofi's asthma drug Dupixent met all targets in a trial to treat "smoker's lung", potentially adding billions to the French drugmaker's growth prospects, but also underscoring...